Does FILGRASTIM-AAFI Cause Neoplasm malignant? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Neoplasm malignant have been filed in association with FILGRASTIM-AAFI. This represents 2.5% of all adverse event reports for FILGRASTIM-AAFI.
11
Reports of Neoplasm malignant with FILGRASTIM-AAFI
2.5%
of all FILGRASTIM-AAFI reports
5
Deaths
3
Hospitalizations
How Dangerous Is Neoplasm malignant From FILGRASTIM-AAFI?
Of the 11 reports, 5 (45.5%) resulted in death, 3 (27.3%) required hospitalization.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FILGRASTIM-AAFI. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does FILGRASTIM-AAFI Cause?
Death (63)
Off label use (63)
White blood cell count decreased (28)
Hospitalisation (17)
Bone pain (15)
Malaise (15)
Needle issue (15)
Pyrexia (15)
Pain (14)
Device leakage (11)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which FILGRASTIM-AAFI Alternatives Have Lower Neoplasm malignant Risk?
FILGRASTIM-AAFI vs FILGRASTIM-SNDZ
FILGRASTIM-AAFI vs FINASTERIDE
FILGRASTIM-AAFI vs FINASTERIDE\TAMSULOSIN
FILGRASTIM-AAFI vs FINERENONE
FILGRASTIM-AAFI vs FINGOLIMOD